headache relief
Generic: acetaminophen, aspirin, caffeine
Labeler: strive pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
headache relief
Generic Name
acetaminophen, aspirin, caffeine
Labeler
strive pharmaceuticals inc.
Dosage Form
TABLET, COATED
Routes
Active Ingredients
acetaminophen 250 mg/1, aspirin 250 mg/1, caffeine 65 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
70692-142
Product ID
70692-142_00e058cb-e1ef-486d-aaee-9aaff1a2a674
Product Type
HUMAN OTC DRUG
Marketing Category
OTC MONOGRAPH DRUG
Application Number
M013
Listing Expiration
2026-12-31
Marketing Start
2023-04-06
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
70692142
Hyphenated Format
70692-142
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
headache relief (source: ndc)
Generic Name
acetaminophen, aspirin, caffeine (source: ndc)
Application Number
M013 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 250 mg/1
- 65 mg/1
Packaging
- 300 TABLET, COATED in 1 BOTTLE (70692-142-31)
Packages (1)
Ingredients (3)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "00e058cb-e1ef-486d-aaee-9aaff1a2a674", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "upc": ["0370692000306"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["308297"], "spl_set_id": ["c0de0bd2-4868-46dc-a20f-3ca02caaa26b"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Strive Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "300 TABLET, COATED in 1 BOTTLE (70692-142-31)", "package_ndc": "70692-142-31", "marketing_start_date": "20230406"}], "brand_name": "Headache Relief", "product_id": "70692-142_00e058cb-e1ef-486d-aaee-9aaff1a2a674", "dosage_form": "TABLET, COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "70692-142", "generic_name": "Acetaminophen, Aspirin, Caffeine", "labeler_name": "Strive Pharmaceuticals Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Headache Relief", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20230406", "listing_expiration_date": "20261231"}